reports
Enphase Energy Expands Safe Harbor Agreement with a Leading TPO Provid...
Enphase Energy Expands Safe Harbor Agreement with a Leading TPO Provider FREMONT, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced a newly expanded safe harbor agreement with a leading solar financing company that offers third-party ownership (TPO) agreements to homeowners, including leases and power purchase agreements (PPAs). The newly expanded safe harbor agreement builds on a prior transaction with this leading TPO provider that was announced...
Centessa Pharmaceuticals Announces CEO Transition as Company Advances ...
Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications Mario Alberto Accardi PhD, President and founder of Centessa’s Orexin Program, appointed Chief Executive Officer and member of the Board of Directors BOSTON and LONDON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that its Board of Directors has appointed Mario Alberto Accardi PhD, President and founder of Centessa’s Orexin Program, as Chief Executive O...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing ...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on December 3, 2025, the Compensation Committee of Taysha's Board of Directors granted two new employees, in the aggregate, options to purchase 212,000 shares of the Company's common stock in connecti...
Enphase Energy Inc: 1 director
A director at Enphase Energy Inc sold 150,000 shares at 29.128USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Enphase Energy Begins Shipments of IQ EV Charger 2 in the United State...
Enphase Energy Begins Shipments of IQ EV Charger 2 in the United States FREMONT, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the first production shipments of its next-generation to customers across the United States. Designed in a sleek, modern black form factor, the IQ EV Charger 2 brings a premium aesthetic to home charging – pairing minimalist styling with rugged durability – and is designed to work seamlessly with Enphase solar and batt...
Enphase Energy Introduces PowerMatch Technology in Europe to Deliver M...
Enphase Energy Introduces PowerMatch Technology in Europe to Deliver More Usable Battery Energy and Savings FREMONT, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of PowerMatch™ technology in Europe. PowerMatch intelligently adjusts IQ® Battery output to match a home’s real-time power needs, delivering more usable energy, longer battery life, and greater long-term savings. Watch a about how it works. Unlike hybrid systems that pus...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
MTH MERITAGE HOMES CORPORATION
DHI D.R. HORTON INC.
COLM COLUMBIA SPORTSWEAR COMPANY
VFC V.F. CORPORATION
HBB HAMILTON BEACH BRANDS HOLDING COMPANY
TNDM TANDEM DIABETES CARE
QTRX QUANTERIX CORPORATION
WGO WINNEBAGO INDUSTRIES INC.
NRIX NURIX THERAPEUTICS
TNGX TANGO THERAPEUTICS INC
FTREV FORTREA HOLDINGS INC.
BBNX BETA BIONICS
SION SIONNA THERAPEUTICS INC
Enphase Energy Announces New Safe Harbor Agreement with a Leading TPO ...
Enphase Energy Announces New Safe Harbor Agreement with a Leading TPO Provider FREMONT, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced a new safe harbor agreement with a leading solar and battery financing company that offers third-party ownership (TPO) agreements to homeowners, including leases and power purchase agreements (PPAs). This is the third safe harbor agreement for Enphase since the new U.S. federal budget bill was signed into law in ...
Enphase Energy Expands IQ Meter Collar Approvals in the United States,...
Enphase Energy Expands IQ Meter Collar Approvals in the United States, including PG&E in California FREMONT, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced an expanded number of utilities have approved the Enphase IQ® Meter Collar for behind-the-meter installation. Pacific Gas and Electric Company (PG&E) and have approved the device for use in their service territories, along with 46 additional utilities across the United States. Many additiona...
- Jonathan Moreland
RGP RESOURCES CONNECTION INC.
FTAI FORTRESS TRANSPORTATION AND INFRASTRUCTURE INVESTORS LLC
FAST FASTENAL COMPANY
TZOO TRAVELZOO
ITGR INTEGER HOLDINGS CORPORATION
BX THE BLACKSTONE GROUP L.P.
REZI RESIDEO TECHNOLOGIES
AEYE INC.
BW AUDIOEYE INC
PNTG BABCOCK & WILCOX ENTERPRISES
MRVI PENNANT GROUP
UPST MARAVAI LIFESCIENCES HOLDINGS
NEXT UPSTART HOLDINGS
CLVT NEXT CAPITAL
OGN CLARIVATE PLC
MYPS ORGANON & CO
FRST PLAYSTUDIOS INC
RBA PRIMIS FINANCIAL CORP
CRVO RITCHIE BROS AUCTIONEERS INC.
GAM CERVOMED INC
MDRR GENERAL DE ALQUILER DE MAQUINARIA
SENS MEDALIST DIVERSIFIED REIT INC.
BATRK SENSEONICS HOLDINGS INC.
LIBERTY MEDIA CORP
- Jonathan Moreland
BLMN BLOOMIN' BRANDS INC.
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
DLY LYONDELLBASELL INDUSTRIES NV
KMPR KEMPER CORPORATION
GOOD GLADSTONE COMMERCIAL CORPORATION
FLDM FLUIDIGM
CROX CROCS INC.
ASA ASA
AROW ARROW FINANCIAL CORP.
LPX LOUISIANA-PACIFIC CORPORATION
SXC SUNCOKE ENERGY INC.
TAP MOLSON COORS BEVERAGE COMPANY CLASS B
REZI RESIDEO TECHNOLOGIES
FSK INC.
WU FS KKR CAPITAL CORP
AEYE THE WESTERN UNION COMPANY
AMCR AUDIOEYE INC
AIMD.P AMCOR PLC
DKNG AIM4 VENTURES
OPEN DRAFTKINGS INC
ACVA OPENDOOR TECHNOLOGIES INC.
FRSH ACV AUCTIONS INC.
TRDA FRESHWORKS INC.
SG ENTRADA THERAPEUTICS INC
FRST SWEETGREEN INC
BLND PRIMIS FINANCIAL CORP
GTE ETRACS DJ-UBS COMMODITY INDEX 2-4-6 BLEND
LAW GRAN TIERRA ENERGY INC.
MRAI CS DISCO INC
GF MARPAI
RMI INC.
THE NEW GERMANY FUND
INC.
RIVERNORTH OPPOR MUN INC FD INC
Enphase Energy Announces Partnership with Green Mountain Power to Laun...
Enphase Energy Announces Partnership with Green Mountain Power to Launch Innovations in Vermont including the Home Battery Lease Program FREMONT, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced a new partnership with Green Mountain Power (GMP) in Vermont to launch innovations benefitting customers through technology and grid transformation. GMP selected Enphase to join its groundbreaking home where customers have back up power when they need it ...
Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offe...
Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares BOSTON and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced the pricing of an underwritten public offering of 11,627,907 American Depositary Shares (“ADSs”), each representing one ordinary share, at a price to the public of $21.50 per ADS. The aggregate gross proceeds to Centessa from this offering are expected to be approximately $250 million, before deducting underwriting discounts and comm...
Centessa Pharmaceuticals Announces Proposed Public Offering of America...
Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares BOSTON and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company, today announced that it has commenced an underwritten public offering of American Depositary Shares (“ADSs”), each representing one ordinary share. All of the ADSs are being offered by Centessa. In addition, Centessa intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the ADSs offered in the public offering. The proposed offeri...
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferenc...
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences BOSTON and LONDON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences: Event: Guggenheim 2nd Annual Healthcare Innovation ConferenceDate: Wednesday, November 12, 2025Fireside Chat: 10:30 AM ET Event: Jefferies Global Healthcare Conference in LondonDate: Tuesday, November 18, 2025Fireside Chat: 2:0...
Enphase Energy IQ8 Microinverters Power Solar Projects at Gas Stations...
Enphase Energy IQ8 Microinverters Power Solar Projects at Gas Stations Worldwide FREMONT, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that its IQ8™ Microinverters have been selected for gas station solar projects around the world, helping businesses deploy clean, reliable energy in some of the most safety-critical commercial environments. Enphase microinverters are uniquely suited to gas station installations thanks to their AC-based system ...
Centessa Pharmaceuticals Reports Financial Results for the Third Quart...
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program ORX750: Demonstrated potential best-in-class profile for treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH) in initial cohorts of ongoing Phase 2a study; Data mark first robust demonstration of oral OX2R agonist addressing wakefulness needs of patients across all three indications; Expect to initiate registrational program in Q1 2026ORX142: Phase 1 data support highly differentiate...
Enphase Energy Announces IQ Battery Systems Now Eligible for San Diego...
Enphase Energy Announces IQ Battery Systems Now Eligible for San Diego Community Power’s Solar Battery Savings Program FREMONT, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that its IQ® Battery systems are now eligible for San Diego Community Power’s (Community Power) Solar Battery Savings program. Community Power is a leading California community choice aggregator serving nearly one million customers across the greater San Diego region. The ...
Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and...
Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update TSHA-102 granted Breakthrough Therapy designation by FDA Finalized FDA alignment on REVEAL pivotal trial protocol and SAP, including 6-month interim analysis that may expedite BLA submission, which was enabled by the rigorous developmental milestone evaluation in Part A REVEAL Phase 1/2 trials showing an unprecedented response rate Dosing of first patient in REVEAL pivotal trial scheduled for Q4 2025, with enrollment of additional patients expected to continue at multiple sites this quarte...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.